|
| 37603323 | Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics. | Neuro Oncol | 2024 |
| 37379361 | Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity. | Cancer Res Commun | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 34965961 | Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory. | Mol Cancer Ther | 2022 |
| 35767439 | Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma. | N Engl J Med | 2022 |
| 35580289 | A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology. | Am Soc Clin Oncol Educ Book | 2022 |
| 35702422 | Remission of liquid tumors and SARS-CoV-2 infection: A literature review. | Mol Ther Oncolytics | 2022 |
| 35393952 | Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas. | JCI Insight | 2022 |
| 35902132 | Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. | J Immunother Cancer | 2022 |
| 35176144 | Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies. | Clin Cancer Res | 2022 |
| 33376098 | Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET. | Clin Cancer Res | 2021 |
| 33795384 | Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy. | J Immunother Cancer | 2021 |
| 33524949 | Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations. | Neurosurg Focus | 2021 |
| 34888488 | Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs. | Arch Clin Biomed Res | 2021 |
| 34450587 | Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. | J Neurosurg | 2021 |
| 34214494 | Hitchhiking to brain tumours: stem cell delivery of oncolytic viruses. | Lancet Oncol | 2021 |
| 34059921 | An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus. | Neuro Oncol | 2021 |
| 34281988 | CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models. | J Immunother Cancer | 2021 |
| 32905473 | miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs. | Arch Clin Biomed Res | 2020 |
| 33231254 | Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model. | Neurosurgery | 2020 |
| 31138805 | The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. | Nat Commun | 2019 |
| 31608328 | GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory. | Neurooncol Adv | 2019 |
| 31348516 | Antitumor immune response during glioma virotherapy. | Neuro Oncol | 2019 |
| 31455679 | Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas. | Clin Cancer Res | 2019 |
| 31036068 | Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models. | Acta Neuropathol Commun | 2019 |
| 29016843 | Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. | Neuro Oncol | 2018 |
| 29987215 | Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors. | Cancers (Basel) | 2018 |
| 29635349 | Linking inflammation and cancer: the unexpected SYK world. | Neuro Oncol | 2018 |
| 29432077 | Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. | J Clin Oncol | 2018 |
| 29594041 | DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report. | Front Oncol | 2018 |
| 29088386 | Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients. | Neurosurgery | 2018 |
| 28760776 | TIE2 Associates with Caveolae and Regulates Caveolin-1 To Promote Their Nuclear Translocation. | Mol Cell Biol | 2017 |
| 28138026 | Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. | Mol Cancer Ther | 2017 |
| 28944168 | Normalizing Tumoral Vessels to Treat Cancer: An Out-of-the-Box Strategy Involving TIE2 Pathway. | Transl Cancer Res | 2017 |
| 28855213 | Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. | Cancer Res | 2017 |
| 28566332 | Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. | Cancer Res | 2017 |
| 26951384 | Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51. | Neuro Oncol | 2016 |
| 27669421 | Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells. | PLoS One | 2016 |
| 27757426 | TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1. | Sci Adv | 2016 |
| 27121320 | Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. | Oncotarget | 2016 |
| 27093696 | Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens. | PLoS One | 2016 |
| 26910374 | Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas. | Oncotarget | 2016 |
| 26799652 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). | Autophagy | 2016 |
| 25619840 | C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. | Oncogene | 2015 |
| 26661633 | Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells. | IEEE Trans Nanobioscience | 2015 |
| 26440941 | MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation. | PLoS One | 2015 |
| 25863716 | Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints. | Curr Opin Virol | 2015 |
| 25925380 | Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model. | Neoplasia | 2015 |
| 24737304 | The oncolytic adenovirus ο24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity. | J Bone Miner Res | 2014 |
| 25954598 | Healing after death: antitumor immunity induced by oncolytic adenoviral therapy. | Oncoimmunology | 2014 |